Chiba S, Itoga T, Asada K, Yabe D, A Prediction Model for Diabetes Complications Using the Kokuho Database and Its Application to Public Health Services in Japan. J Diabetes Investig. In press.
Ueba Y, Ikeda K, Tabara Y, Nakayama T, Tanaka D, Takahashi Y, Kosugi S, Setoh K, Kawaguchi T, Matsuda F, Inagaki N. Dietary patterns rich in soybean products, vegetables, fish, fruits, and miso soup were inversely associated with fatty liver index: The Nagahama Study. J Nutr Sci Vitaminol. In press.
Lingvay I, Benamar M, Chen L, Fu A, Jódar E, Nishida T, Riveline JP, Yabe D, Zueger T, Rea R. Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial. Diabetologia. In press.
Seiji N, Hirota Y, Yasushi N, Ishii M, Ohsugi M, Maeda E, Yoshimura K, Yamamoto A, Takayoshi T, Kato T, Yabe D, Matsuhisa M, Eguchi J, Wada J, Fujita Y, Kume S, Maegawa H, Miyake K, Shojima N, Yamauchi T, Yokote K, Ueki K, Miyo K, Ogawa W. Relation between obesity and health disorders as revealed by the J-ORBIT clinical information collection system directly linked to electronic medical records (J-ORBIT 1). J Diabetes Investig. In press.
Yamauchi I, Sugawa T, Hakata T, Yoshizawa A, Kita T, Kishimoto Y, Kimura S, Sakurai A, Kosugi D, Fujita H, Okamoto K, Ueda Y, Fujii T, Taura D, Sakane Y, Yasoda A, Inagaki N. Transcriptomic landscape of hyperthyroidism in mice overexpressing thyroid-stimulating hormone. iScience. 2024; 28: 111565.
Shoji T, Yamauchi I, Kawasaki H, Iwanaga K, Hakata T, Tanaka D, Fujikura J, Masui T, Suzuki H, Yamada M, Kosaki K, Kasai Y, Hatano E, Inaba A, Wada T, Kosugi S, Ueda Y, Fujii T, Taura D and Inagaki N. Duplication of the GCK gene is a novel cause of nesidioblastosis: evidence from a case with Silver-Russell syndrome-like phenotype related to chromosome 7. Front. Endocrinol. 2024; 15: 1431547.
Deguchi K, Ushiroda C, Kamei Y, Kondo K, Tsuchida H, Seino Y, Yabe D, Suzuki A, Nagao S, Iizuka K. Glucose and Insulin Differently Regulate Gluconeogenic and Ureagenic Gene Expression. J Nutr Sci Vitaminol (Tokyo). 2025;71(1):46-54.
Yang Y, Yamane S, Harada N, Ikeguchi-Ogura E, Yamamoto K, Wada N, Fauzi M, Murakami T, Yabe D, Hayashi Y, Inagaki N. Voltage-gated calcium channel α2δ-1 subunit is involved in the regulation of glucose-stimulated GLP-1 secretion in mice. Am J Physiol Gastrointest Liver Physiol. 328(3):G243-G251, 2025.
Deguchi K, Ushiroda C, Hidaka S, Tsuchida H, Yamamoto-Wada R, Seino Y, Suzuki A, Yabe D, Iizuka K. Chrebp deletion and mild protein restriction additively decrease muscle and bone mass and function. Nutrients. 2025;17(3):488.
Ikeda K, Mano-Usui F, Kishimoto Y, Yabe D, Inagaki N, Omori K, Nagai Y. Concurrent SGLT2 inhibitor use in patients with type 2 diabetes hospitalized for high-dose corticosteroid therapy: mitigated iatrogenic hyperglycemia. Diabetes, Obes Metab. 27(4):2305-2308, 2025.
Lu X, Harada N, Yasuda T, Ikeguchi-Ogura E, Kobayashi D, Denda M, Seno Y, Yamane S, Yabe D, Otaka A, Inagaki N. Effects of tryptophan-selective lipidated GLP-1 peptides on the GLP-1 receptor. J Endocrinol. 264(3):e240026, 2025.
Komura Y, Inoue K, Ishimura N, Taura D, Harada N, Inagaki N, Kondo N. Diabetes and suicide: a nationwide longitudinal cohort study among the Japanese working-age population. J Epidemiol Community Health.2024 Nov 27:jech-2024-222701.
Fujiwara N, Haze T, Tamura K, Tsuiki M, Kamemura K, Taura D, Ichijo T, Takahashi Y, Watanabe M, Kobayashi H, Izawa S, Wada N, Yamada T, Yokota K, Naruse M, Sone M, JPASⅡstudy group. Differences in target organ damage between captopril challenge test-defined definitive-positive and borderline-range groups among patients with primary aldosteronism. Hypertens Res 48(2):540-552, 2025.
Hakata T, Yamauchi I, Kosugi D, Sugawa T, Fujita H, Okamoto K, Ueda Y, Fujii T, Taura D, Inagaki N.
High-throughput Screening for Cushing Disease: Therapeutic Potential of Thiostrepton via Cell Cycle Regulation.
Endocrinology. 165(9):bqae089, 2024.
Wada N, Murakami T, Fauzi M, Sakaki K, Oshima S, Okawa A, Shimada Y, Oshima A, Nomura S, Joo E, Mori M, Fujiwara R, Shide K, Wada K, Yabe D, Inagaki N, Harada N. Elevated serum GDF15 levels as a potential biomarker of the efficacy of imeglimin in individuals with type 2 diabetes mellitus: An exploratory study. J Clin Med Res. 16(10):503-508, 2024.
Hirose M, Inoue K, Matoba S, Tatebe T, Tokita S, Dodo Y, Tomishima T, Hasegawa A, Honda A, Ozaki M, Shinogi A, Yanagisawa R, Fauzi M, Murakami T, Inagaki N, Tamura M, Ogura A. Disruption of insulin receptor substrate 2 (IRS2) causes non-obese type 2 diabetes with β-cell dysfunction in the golden (Syrian) hamster. Sci Rep. 14: 17450, 2024.
Yabe D, Hamamoto Y, Kawanami D, Nishimura R, Terauchi Y, Amadid H, Braae UC, Major-Pedersen A, Suzuki R. PIONEER REAL Japan: Primary results from a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practice. J Diabetes Investig. 15(11):1566-1577, 2024.
Nishida K, Ueno S, Seino Y, Hidaka S, Murao N, Asano Y, Fujisawa H, Shibata M, Takayanagi T, Ohbayashi K, Iwasaki Y, Iizuka K, Okuda S, Tanaka M, Fujii T, Tochio T, Yuuichiro Yamada, Yabe D, Sugimura Y, Hirooka Y, Hayashi Y, Suzuki A. High Fat Diet-Induced Hepatic Triglyceride Accumulation Is Reduced in Mice Deficient in Proglucagon-Derived Peptides, Likely Due Primarily To Reduced Fat Absorption In The Intestinal Tract. Nutrients. 16(14), 2270, 2024.
Iizuka K, Deguchi K, Ushiroda C, Yanagi K, Seino Y, Suzuki A, Yabe D, Sasaki H, Sasaki S, Saitoh E, Naruse H. The study on compatibility of a food recording application and questionnaire-based methods in healthy Japanese individuals.
Nutrients. 16(11): 1742, 2024.
Suzuki R, Amadid H, Major-Pedersen A, Yabe D. PIONEER REAL Japan: Baseline characteristics of a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in clinical practice in Japan. J Diabetes Investig. 15(8):1047-1056, 2024.
Sachiko Tsukamoto-Kawashima, Ikeda K, Sone M, Ogura M, Okamura E, Kondo A, Ueba Y, Inagaki N. An exploratory study of factors in disordered eating behavior in diabetes self‐management in Japan. J Diabetes Investig. 15(7): 874–881, 2024.
Sugimoto T, Araki A, Fujita H, Fujita K, Honda K, Inagaki N, Ishida T, Kato J, Kishi M, Kishino Y, Kobayashi K, Kouyama K, Kuroda Y, Kuwahata S, Matsumoto N, Murakami T, Noma H, Ogino J, Ogura M, Ohishi M, Shimada H, Sugimoto K, Takenaka T, Tamura Y, Tokuda H, Uchida K, Umegaki H, Sakurai T. Multidomain Intervention Trial for Preventing Cognitive Decline among Older Adults with Type 2 Diabetes: J-MIND-Diabetes. J Prev Alzheimers Dis. 11(6):1604-1614, 2024.
Hakata T, Ueda Y, Yamashita T, Yamauchi I, Kosugi D, Sugawa T, Fujita H, Okamoto K, Fujii T, Taura D, Yasoda A, Akiyama H, Inagaki N. Neprilysin Inhibition Promotes Skeletal Growth via the CNP/NPR-B Pathway. Endocrinology. 165: bqae058, 2024
Yamauchi I, Yasoda A, Hakata T, Yamashita T, Hirota K, Ueda Y, Fujii T, Taura D, Sone M, Inagaki N. Novel Thyroid-Specific Autoantibodies in Patients with Immune-Related Adverse Events Involving the Thyroid Gland. Thyroid Science. 1: 100009, 2024.
Inoguchi K, Anazawa T, Fujimoto N, Tada S, Yamane K, Emoto N, Izuwa A, Su H, Fujimoto H, Murakami T, Nagai K, Hatano E. Impact of Prevascularization on Immunological Environment and Early Engraftment in Subcutaneous Islet Transplantation. Transplantation. 108:1115-1126, 2024.
Nakano E, Mukai K, Fukuhara A, Otsuki M, Shimomura I, Ichijo T, Tsuiki M, Wada N, Yoneda T, Takeda Y, Oki K, Yamada T, Ogawa Y, Yabe D, Kakutani M, Sone M, Katabami T, Tanabe A, Mitsuhide N. Primary aldosteronism patients with previous cardiovascular and cerebrovascular events have high aldosterone responsiveness to ACTH stimulation.
Endocr J. 71(5):489-497, 2024.
（２）英文症例報告
Naito A, Nakajima S, Nakano H, Furuta K, Irie H, Hakata T, Yamauchi I, Fujimoto M, Kambe N, Kabashima K.
A case of non-uremic calciphylaxis in a patient with secondary hyperparathyroidism and panhypopituitarism
J Dermatol. In press.
Kondo, K., Minamino, H., Murakami, T. Okamura E, Hakata T, Ueda Y, Taura D, Yabe D. Longitudinal monitoring of urinary C-peptide levels following discontinuation of sacubitril/valsartan in a type 2 diabetes patient: a case report and literature review. Diabetol Int. In press.
Takahashi Y, Matsuyama Y, Asai K, Endo J, Yabe D. A Novel Multiple Endocrine Neoplasia Type 1 Gene Variant Found in Scalp Pulmonary Neuroendocrine Tumor Metastasis. JCEM Case Reports. In press.
Nakao T, Takeshima K, Morita S, Yamauchi I, Koyasu S, Matsuoka TA. Tumor-Induced Osteomalacia Localized by Systemic Venous Sampling and 68Ga-DOTATOC Positron Emission Tomography. JCEM Case Rep. 2025; 3: luaf012.
Yoshida H, Takaaki Murakami T, Ogawa A, Sunouchi T, Hidaka N, Ito N, Murakami H, Kawasaki H, Akiyama T, Nakajima K, Mizuno N, Yabe D, Yamamoto T. Adult hypophosphatasia presenting with repeated acute joint pain and low serum alkaline phosphatase: A case report and literature review. Endocrinology, Diabetes and Metabolism Case Reports. 2025;2025(1):e240121.
Shoji T, Yamauchi I, Kawasaki H, Iwanaga K, Hakata T, Tanaka D, Fujikura J, Masui T, Suzuki H, Yamada M, Kosaki K, Kasai Y, Hatano E, Inaba A, Wada T, Kosugi S, Ueda Y, Fujii T, Taura D and Inagaki N. Duplication of the GCK gene is a novel cause of nesidioblastosis: evidence from a case with Silver-Russell syndrome-like phenotype related to chromosome 7. Front. Endocrinol. 2024; 15: 1431547.
Imai R, Sakai M, Kato T, Ozeki S, Kubota S, Liu Y, Takahashi Y, Takao K, Mizuno M, Hirota T, Horikawa Y, Murakami T, Kanayama T, Kuroda T, Miyazaki T, Yabe D. Hypovascular insulinoma with reduced microvessel density on histopathology: A case report. Diabetol Int. 15(4):855-860, 2024.
Ito Y, Imaizumi T, Daido H, Kato T, Yabe D. Sporadic Parathyroid Carcinoma Treated with Lenvatinib, Exhibiting a Novel Somatic MEN1 Mutation. JCEM Case Rep. 2: luae121, 2024.
Otani D, Murakami T, Murakami S, Hanaoka I, Fujimoto H, Shimizu Y, Kawai Miyake K, Sakaki K, Ueda Y, Tanaka D, Ohno Y, Shimizu H, Uyama N, Iizuka N, Yabe D, Nakamoto Y, Inagaki N. [18F]FB(ePEG12)12-exendin-4 noninvasive imaging of insulinoma in the pancreatic head despite insulin-negative findings on endoscopic ultrasonography-guided fine needle aspiration: A case report with review of literature. Endocr J. 71(9):925-933, 2024.
Haba T, Yamakawa K, Ozeki S, Sumida A, Kato T, Kuroda E, Maruyama T, Murakami T, Yabe D. A case of insulinoma misidentified as schizophrenia due to its manifestation in neuropsychiatric symptoms. Diabetol Int. 15(3):611-615, 2024.
（３）英文総説
Seno Y, Ikeguchi E, Yabe D. Evolving Incretin-Based Therapies in Japan: Optimizing Treatment Strategies for Diverse Clinical and Socioeconomical Profiles in Type 2 Diabetes. Diabetol Int. In Press.
Yamauchi I, Yabe D. Best practices in the management of thyroid dysfunction induced by immune checkpoint inhibitors. Eur Thyroid J. (2025) ETJ-24-0328.
Fujikura J, Anazawa T, Toyoda T, Ito R, Kimura Y, Yabe D. Towards a Cure for Diabetes: iPSC and ESC-Derived Islet Cell Transplantation Trials. J Diabetes Investig. In Press.
Seino Y, Yabe D, Tsumura K, Huang CN, Kim SH, Jia W, Khasag A, Kadowaki T. The Ulaanbaatar Agreement: Revising Diabetes Terminology in Asia to Combat Stigma. J Diabetes Investig.15(11):1533-1536, 2024.
Yabe D. Harnessing the Therapeutic Potential of SGLT2 Inhibitors in Type 2 Diabetes: Challenges and Opportunities.
JMA J. 7(3):401-402, 2024.
Bouchi R, Kondo T, Ohta Y, Goto A, Tanaka D, Satoh H, Yabe D, Nishimura R, Harada N, Kamiya H, Suzuki R, Yamauchi T. A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2 diabetes – 2nd edition (English version). J Diabetes Investig. 15(9):1326-1342, 2024.
Bouchi R, Kondo T, Ohta Y, Goto A, Tanaka D, Satoh H, Yabe D, Nishimura R, Harada N, Kamiya H, Suzuki R, Yamauchi T. A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2 diabetes – 2nd edition (English version). Diabetol Int. 15(3):327-345, 2024.
Ambrosini V, Fortunati E, Fanti S, Ursprung S, Asmundo L, O’Shea A, Kako B, Lee S, Furtado FS, Blake M, Goiffon RJ, Najmi Z, Hesami M, Murakami T, Domachevsky L, Catalano OA. State-of-the-Art Hybrid Imaging of Neuroendocrine Neoplasms. J Comput Assist Tomogr. 48(4):510-520, 2024.
（４）英文その他
Murakami T. The 125th Anniversary of the Publication of the College. Kyoto University Graduate School of Medicine and Faculty of Medicine 125th Anniversary Commemorative Publication. 2024.11
Daisuke Yabe “Personalized diabetes therapy considering disease pathophysiology: How to effectively and safely utilize SGLT2 inhibitors” 17th Scientific Meeting of the Asian Association for the Study of Diabetes/46th Annual Meeting of Diabetes Association of Republic of China and Endocrine Society of Republic of China, Lecture (Taipei/Taiwan, March 28-30, 2025)
Daisuke Yabe “Diabetes Advocacy in Asia: Addressing Treatment Access, Prevention and Stigma Through Collaborative Efforts” 17th Scientific Meeting of the Asian Association for the Study of Diabetes/46th Annual Meeting of Diabetes Association of Republic of China and Endocrine Society of Republic of China. Symposium. (Taipei/Taiwan, March 28-30, 2025)
Daisuke Yabe “Incretin-Based Therapies for Optimizing Type 2 Diabetes Management in Asia – Focus on Incretin Receptor Agonists” 17th Scientific Meeting of the Asian Association for the Study of Diabetes/46th Annual Meeting of Diabetes Association of Republic of China and Endocrine Society of Republic of China. Symposium. (Taipei/Taiwan, March 28-30, 2025)
Daisuke Yabe “Incretin-Based Therapies for Optimizing Type 2 Diabetes Management in Asia – Focus on Pathophysiology and Mechanisms of Action” 17th Scientific Meeting of the Asian Association for the Study of Diabetes/46th Annual Meeting of Diabetes Association of Republic of China and Endocrine Society of Republic of China. Symposium. (Taipei/Taiwan, March 28-30, 2025)
Daisuke Yabe “Opportunities and Challenges for Precision Medicine in Chronic Disease Management in the Asia-Pacific Region” 17th Scientific Meeting of the Asian Association for the Study of Diabetes/46th Annual Meeting of Diabetes Association of Republic of China and Endocrine Society of Republic of China. Lecture. (Taipei/Taiwan, March 28-30, 2025)
Yoshida H, Murakami T, Wada N, Fauzi M, Sakaki K, Inagaki N, Harada N, Yabe D. Elevation of Serum GDF15 Under Imeglimine Treatment in Patients with Type 2 Diabetes Mellitus. 17th Scientific Meeting of the Asian Association for the Study of Diabetes/46th Annual Meeting of Diabetes Association of Republic of China and Endocrine Society of Republic of China. Short oral. Taipei, March 28-30, 2025.
Yoshida H, Murakami T, Sakaki K, Otani D, Kawai KM, Shimizu Y, Fujimoto H, Yabe D, Nakamoto Y, Inagaki N. Noninvasive Insulinoma Diagnosis Using [18F]FB(ePEG12)12-exendin-4 PET/CT: Interim Report from a Phase II Clinical Trial. 17th Scientific Meeting of the Asian Association for the Study of Diabetes/46th Annual Meeting of Diabetes Association of Republic of China and Endocrine Society of Republic of China. Oral. Taipei, March 28-30, 2025.
Fauzi M, Murakami T, Usui R, Botagarova A, Sakaki K, Tokumoto S, Otani D, Yoshida H, Ogura M, Inagaki N, Yabe D. A novel dual regulator of insulin secretion and hepatic glucose production. 17th Scientific Meeting of the Asian Association for the Study of Diabetes/46th Annual Meeting of Diabetes Association of Republic of China and Endocrine Society of Republic of China. Oral. Taipei, March 28-30, 2025.
Fujita Y, Kira Y, Isomura N, Sakurai N, Inoue M, Suzuki K, Ikeda K, Minamino H, Takesue K, Inagaki N, Yabe D. Elucidation of factors involved in glucose intolerance using health check-up data from the Japanese population. 17th Scientific Meeting of the Asian Association for the Study of Diabetes/46th Annual Meeting of Diabetes Association of Republic of China and Endocrine Society of Republic of China. Poster. Taipei, March 28-30, 2025.
Daisuke Yabe “Incretin, Energy Metabolism and Beyond” The 60th US-Japan Cooperative Medical Sciences Program. Joint Cancer, Nutrition, Immunology and Hepatitis Panel. (Tokyo/Japan, March 12-15, 2025)
Kubota-Okamoto S, Kubota S, Liu Y, Tsuchida H, Fujiwara Y, Kuwata H, Harada N, Yamada Y, Seino Y, Yabe D. GIP is key for DPP-4 inhibitor Anagliptin’s glucose ameliorate in mice. The 60th US-Japan Cooperative Medical Sciences Program. Poster. March 12-15, 2025.
Lu X, Harada N, Yasuda T, Ikeguchi-Ogura E, Kobayashi D, Denda M, Seno Y, Yamane S, Yabe D, Otaka A, Inagaki N. Effects of tryptophan-selective lipidated GLP-1 peptides on the GLP-1 receptor. The 60th US-Japan Cooperative Medical Sciences Program. Poster. March 12-15, 2025.
Imaizumi T, Iizuka K, Yabe D. Chrebp deletion in Akita mice exacerbates skeletal muscle atrophy and weakness. The 60th US-Japan Cooperative Medical Sciences Program. Poster. March 12-15, 2025.
Fauzi M, Murakami T, Usui R, Botagarova A, Sakaki K, Otani D, Tokumoto S, Ogura M, Inagaki N, Yabe D. Regulating Ca2+ Dynamics to Control Insulin Secretion and Hepatic Glucose Production. The 60th US-Japan Cooperative Medical Sciences Program. Poster and Flash Talk. March 12-15, 2025.
Yamauchi I, Hakata T, Sugawa T, Kimura S, Kosugi D, Okamoto K, Ueda Y, Taura D, Yabe D. Management of Thyroid Dysfunction Due to Immune Checkpoint Inhibitors: Lessons from the Real-World Experience. The 93rd Annual Meeting of the American Thyroid Association. Poster. Chicago, USA, October 30-November 3, 2024.
Yamauchi I, Kimura S, Sugawa T, Hakata T, Kosugi D, Okamoto K, Ueda Y, Taura D, Nakajima D, Kubo T, Yabe D. Comprehensive Evaluation of Thyroid Hormone Action Using Hypothyroid Mice. The 93rd Annual Meeting of the American Thyroid Association. Poster. Chicago, USA, October 30-November 3, 2024.
Sugawa T, Yamauchi I, Hakata T, Yoshizawa A, Kita T, Kishimoto Y, Kimura S, Kosugi D, Fujita H, Okamoto K, Ueda Y, Fujii T, Taura D, Sakane Y, Yasoda A, Inagaki N. Transcriptome analysis of a novel hyperthyroid mouse induced by TSH overexpression. The 93rd Annual Meeting of the American Thyroid Association. Poster. Chicago, USA, October 30-November 3, 2024.
Motohashi K, Tokumoto S, Sogawa Y, Kaneko S. Age-related changes in glucagon secretion and effects of preservation of beta cell function on muscle mass in people with type 2 diabetes. European Association for the Study of Diabetes 2024. Short Oral. Madrid, September 9-13, 2024.
Fauzi M, Murakami T, Usui R, Otani D, Sakaki K, Tokumoto S, Ogura M, Inagaki N, Yabe D. Exploring the roles of carbonic anhydrase VIII in hepatic glucose production and its potential for diabetes treatment. European Association for the Study of Diabetes 2024. Oral. Madrid, September 9-13, 2024.
N. Wada, N. Harada, T Hatoko, S. Kiyobayashi, T. Yasuda, K. Yamamoto, X. Lu, Y. Seno, T. Kurihara, S. Yamane, Y. Hayashi, Inagaki N, Yabe D. Sleeve gastrectomy alters intestinal morphology and the number and localisation of incretin-producing cells. European Association for the Study of Diabetes 2024. Short Oral. Madrid, September 9-13, 2024.
Y. Seno, N. Harada, E. Ikeguchi-Ogura, X. Lu, K. Yamamoto, T. Yasuda, H. Tatsuoka, T. Kato, Inagaki N, Yabe D. Characterisation of intestinal K/I cells utilising GIP/CCK double reporter mice. European Association for the Study of Diabetes 2024. Short Oral. Madrid, September 9-13, 2024.
T. Yasuda, N. Harada, T. Hatoko, X. Lu, K. Yamamoto, N. Wada, Y. Seno, T. Kurihara, S. Yamane, Inagaki N, Yabe D. An alteration of intestinal morphology and sugar transporters by long-term administration of SGLT2 inhibitor. European Association for the Study of Diabetes 2024. Short Oral. Madrid, September 9-13, 2024.
K. Yamamoto, N. Harada, T. Yasuda, T. Hatoko, N. Wada, X. Lu, Y. Seno, T. Kurihara, S. Yamane, Yabe D, Inagaki N. Chronic treatment of alfa-glucosidase inhibitor alters intestinal morphology and sugar transport gene expression under high sucrose diet feeding. European Association for the Study of Diabetes 2024. Short Oral. Madrid, September 9-13, 2024.
Yabe D. Incretin, Energy Metabolism and Beyond. International Congress of Diabetes and Metabolism 2024, Symposium, Seoul, Korea, October 9-11, 2024.
Yabe D. SGLT2 inhibitors for older adults with type 2 diabetes: Optimizing appropriate use. International Congress of Diabetes and Metabolism 2024, Symposium, Seoul, Korea, October 9-11, 2024.
Yabe D. Diabetes Care in Japan: Current status and problems to be solved. The 16th AASD Scientific Meeting and 7th UICDE, Symposium. Ulaanbaatar, Mongolia, August 15-17, 2024.
Lu X, Harada N, Yasuda T, Ikeguchi-Ogura E, Kobayashi D, Denda M, Seno Y, Yamane S, Yabe D, Otaka A, Inagaki N. Effect of tryptophan-selective lipidated glp-1 peptides on glp-1 receptor. The 16th AASD Scientific Meeting and 7th UICDE. Oral. Ulaanbaatar, Mongolia, August 15-17, 2024.
Takesue K, Fujita Y, Furuya F, Minamino H, Li Y, Isomura N, He Y, Zhang J, Yabe D, Inagaki N. Exploration of treatment targets for masld through a comparison between sglt2 inhibitors and low carbohydrate diet. The 16th AASD Scientific Meeting and 7th UICDE. Oral. Ulaanbaatar, Mongolia, August 15-17, 2024.
Yabe D. Incretin and Cardiovascular System. KOVAS, Symposium, Seoul, Korea, July 12, 2024.
Muhammad Fauzi. Travel grant. European Association for the Study of Diabetes 2024. Madrid, September 9-13, 2024
吉田駿男. Travel grant. 17th Scientific Meeting of Asian Association for the Study of Diabetes. Taipei, March 28-30, 2025.
吉田駿男. 興和生命科学振興財団. 令和６年度 国際交流助成 2024年11月13日
Muhamad Fauz. Outstanding Poster Award. The 25th International. Conference on Emerging Infectious Diseases (EID) in the Pacific Rim of the USJCMSP. Tokyo. 2025年3月15日.
